Proton Therapy Patient Registry

计划入组 999 人 · 首次发布于 2016 年 12 月 8 日

Proton Therapy Medical Registry

计划入组 6,000 人 · 首次发布于 2021 年 12 月 9 日

Proton Therapy for Mediastinal Lymphoma (PROMLY)

计划入组 139 人 · 首次发布于 2026 年 9 月 14 日

M2 proton channel inhibitors(Ambrilia Biopharma, Inc.)

Autologous T cells therapy(Unicar-Therapy)

CBR/CMR therapy(Hemogenyx)

THE NEW YORK PROTON CENTER

United States

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

First Proton Therapy System Arrives in Nebraska, Ending 'Proton Desert' for Central U.S. Cancer Patients

UW Health Launches Proton Therapy Program for Cancer Patients Through Clinical Trial

PARTIQoL Trial Assesses Proton Therapy vs. IMRT for Localized Prostate Cancer